Jump to content

Quinolinic acid: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

20 November 2023

19 November 2023

17 November 2023

16 November 2023

8 September 2023

15 May 2023

23 October 2022

1 October 2022

24 May 2022

24 April 2022

21 November 2021

3 May 2021

29 March 2021

15 February 2021

31 December 2020

7 December 2020

23 September 2020

12 September 2020

29 June 2020

15 June 2020

5 June 2020

29 May 2020

13 April 2020

18 January 2020

26 December 2019

27 July 2019

2 July 2019

27 June 2019

16 June 2019

5 June 2019

16 April 2019

26 December 2018

15 May 2018

9 March 2018

8 November 2017

18 October 2017

11 October 2017

  • curprev 18:2818:28, 11 October 201762.107.107.32 talk 31,440 bytes +1,042 The cannabinoid WIN 55,212-2, a CB1 receptor agonist, and the endocannabinoid anandamide, partially or completely prevent the QUIN-induced early mitochondrial dysfunction, lipid peroxidation and reactive oxygen species (ROS) formation undo Tag: Visual edit

2 September 2017

27 August 2017

23 August 2017

31 December 2016

10 December 2016

8 November 2016

25 June 2016

13 June 2016

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)